Study to Evaluate Safety and Tolerability of PF-07242813 in Healthy Participants and Participants With Atopic Dermatitis
Clinical trial NCT04668066 · COMPLETED
Trial details
- NCT number
- NCT04668066
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-10
- Primary completion
- 2022-12-27
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.